Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109505306 | 10950530 | 6 | F | 201503 | 20160707 | 20150324 | 20160719 | EXP | US-GLAXOSMITHKLINE-US2015034740 | GLAXOSMITHKLINE | 80.01 | YR | F | Y | 0.00000 | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109505306 | 10950530 | 1 | PS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 2 PUFF(S), QID | Y | TC9M | 20983 | 2 | DF | QID | ||||||
| 109505306 | 10950530 | 2 | SS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | 0 | INHALATION POWDER | |||||||||||
| 109505306 | 10950530 | 3 | SS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | 1 PUFF(S), QD | R680767 | 0 | 1 | DF | INHALATION POWDER | QD | ||||||
| 109505306 | 10950530 | 4 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID (250/50) | 0 | 1 | DF | INHALATION POWDER | BID | ||||||
| 109505306 | 10950530 | 5 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID (500/50) | 0 | 1 | DF | INHALATION POWDER | BID | ||||||
| 109505306 | 10950530 | 6 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 109505306 | 10950530 | 7 | C | DUONEB | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | 0 | ||||||||||||
| 109505306 | 10950530 | 8 | C | BROVANA | ARFORMOTEROL TARTRATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109505306 | 10950530 | 1 | Chronic obstructive pulmonary disease |
| 109505306 | 10950530 | 2 | Chronic obstructive pulmonary disease |
| 109505306 | 10950530 | 4 | Chronic obstructive pulmonary disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109505306 | 10950530 | Adverse drug reaction | |
| 109505306 | 10950530 | Candida infection | |
| 109505306 | 10950530 | Contusion | |
| 109505306 | 10950530 | Drug ineffective | |
| 109505306 | 10950530 | Dry mouth | |
| 109505306 | 10950530 | Dysphonia | |
| 109505306 | 10950530 | Lip swelling | |
| 109505306 | 10950530 | Myalgia | |
| 109505306 | 10950530 | Oral candidiasis | |
| 109505306 | 10950530 | Pollakiuria | |
| 109505306 | 10950530 | Psychomotor hyperactivity | |
| 109505306 | 10950530 | Rhinorrhoea | |
| 109505306 | 10950530 | Tongue geographic | |
| 109505306 | 10950530 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109505306 | 10950530 | 1 | 20160516 | 20160520 | 0 | |
| 109505306 | 10950530 | 2 | 20150312 | 0 | ||
| 109505306 | 10950530 | 3 | 20150319 | 0 | ||
| 109505306 | 10950530 | 4 | 2010 | 2012 | 0 | |
| 109505306 | 10950530 | 5 | 20150408 | 0 |